Quick Answer
Shuttle Pharmaceuticals Holdings, Inc. reported Stockholders Equity of $2.25 million for fiscal year 2025.
Shuttle Pharmaceuticals Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.25M | +217.9% |
| 2024 | $709.2K | -82.5% |
| 2023 | $4.06M | -47.2% |
| 2022 | $7.68M | +571.6% |
| 2021 | -$1.63M | +3.7% |
| 2020 | -$1.69M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.39M | +206.0% | -61.3% |
| June 30, 2025 | $3.61M | +349.9% | +9.7% |
| March 31, 2025 | $3.29M | +19.0% | +363.3% |
| December 31, 2024 | $709.2K | -82.5% | +153.9% |
| September 30, 2024 | -$1.32M | -123.4% | -264.1% |
| June 30, 2024 | $801.4K | -88.4% | -71.0% |
| March 31, 2024 | $2.76M | -60.0% | -31.9% |
| December 31, 2023 | $4.06M | -47.2% | -27.7% |
- Shuttle Pharmaceuticals Holdings, Inc. showed an increase of +217.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Shuttle Pharmaceuticals Holdings, Inc.’s stockholders equity has grown by 233.4% (from -$1.69 million to $2.25 million).
- The most recent figure is from Shuttle Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: